Collegium Pharmaceutical, Inc.
COLL
$27.27
$0.220.81%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | 69.19M | 88.59M | 99.89M | 93.29M | 48.16M |
| Total Depreciation and Amortization | 169.16M | 148.11M | 143.52M | 146.41M | 149.26M |
| Total Amortization of Deferred Charges | 6.02M | 6.56M | 7.47M | 8.13M | 8.64M |
| Total Other Non-Cash Items | 15.59M | 24.30M | 26.92M | 20.21M | 46.97M |
| Change in Net Operating Assets | -54.98M | -73.89M | -1.11M | 40.98M | 21.73M |
| Cash from Operations | 204.98M | 193.67M | 276.69M | 309.02M | 274.75M |
| Capital Expenditure | -1.65M | -1.25M | -1.07M | -853.00K | -461.00K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -267.54M | -267.54M | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -18.57M | -32.31M | -54.89M | -87.91M | -70.35M |
| Cash from Investing | -287.76M | -301.09M | -55.95M | -88.76M | -70.81M |
| Total Debt Issued | 325.00M | 319.46M | 6.28M | 5.85M | 241.50M |
| Total Debt Repaid | -305.66M | -335.34M | -216.55M | -183.33M | -301.14M |
| Issuance of Common Stock | 11.07M | 14.14M | 14.11M | 9.65M | 9.10M |
| Repurchase of Common Stock | -79.20M | -79.12M | -129.15M | -88.50M | -83.36M |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -11.83M | -6.28M | -6.28M | -6.28M | -6.28M |
| Cash from Financing | -60.60M | -87.15M | -331.59M | -262.62M | -140.18M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -143.38M | -194.57M | -110.86M | -42.37M | 63.76M |